Results 171 to 180 of about 412,436 (221)
Some of the next articles are maybe not open access.
Journal of the American Veterinary Medical Association, 1970
SUMMARY Clinical, laboratory, and pathologic findings in a case of polycythemia vera in a cat were recorded. Hematologic findings indicated marked polycythemia in the absence of a secondary cause. The red cell mass as measured directly by the 51Cr technique was markedly increased, whereas the plasma volume was normal.
C, Reed +3 more
openaire +2 more sources
SUMMARY Clinical, laboratory, and pathologic findings in a case of polycythemia vera in a cat were recorded. Hematologic findings indicated marked polycythemia in the absence of a secondary cause. The red cell mass as measured directly by the 51Cr technique was markedly increased, whereas the plasma volume was normal.
C, Reed +3 more
openaire +2 more sources
The treatment of polycythemia vera
Journal of Chronic Diseases, 1957p” LYCYTHEMIA vera is a chronic disease of unknown etiology, the chief clinical manifestations of which are headaches, fatigability, dizziness, pruritus, splenomegaly, plethora, cyanosis, and systolic hypertension. Elevations of the erythrocyte level, the hemoglobin concentration, and the hematocrit value constitute the most consistent laboratory ...
E H, REINHARD, B, HAHNEMAN
openaire +2 more sources
Chemotherapy in Polycythemia Vera
Acta geneticae medicae et gemellologiae, 1968Summary210 cases of polycythemia vera were observed over a period of 15 years. The majority of them received P32; treatment with Myleran instead of with radioactive phosphorus was instituted only recently. To a small number of patients chemotherapy was given alternately with P32.
G, Stecher, G, Reinhardt
openaire +2 more sources
The Hypercoagulability of Polycythemia Vera
Hospital Practice, 1993Thrombosis is the most common cause of death in patients with this myeloproliferative syndrome. Phlebotomy, hydroxyurea, and antiplatelet agents are the mainstays of therapy but may not stave off a lethal embolism.
W, Fields, N J, Freeman
openaire +2 more sources
Clinical Journal of Oncology Nursing, 2003
Polycythemia vera (PV) is a clonal stem cell disorder characterized by increased erythrocyte production. Its etiology is not fully understood, and hemorrhage, thrombosis, and hyperviscosity may occur at any time during the course of this disorder. Treatment depends on the most affected cell type, duration and severity of the condition, and patient age.
openaire +2 more sources
Polycythemia vera (PV) is a clonal stem cell disorder characterized by increased erythrocyte production. Its etiology is not fully understood, and hemorrhage, thrombosis, and hyperviscosity may occur at any time during the course of this disorder. Treatment depends on the most affected cell type, duration and severity of the condition, and patient age.
openaire +2 more sources
POLYCYTHEMIA VERA AND GLOMERULONEPHRITIS
Australian and New Zealand Journal of Medicine, 1983Abstract: Six patients with polycythemia vera and proteinuria are described. Three patients had histologically defined glomerulonephritis. It is proposed that there is an association between polycythemia vera and the development of glomerulonephritis. Possible pathogenetic mechanisms are discussed.
R F, Plomley +5 more
exaly +3 more sources
Journal of the American Veterinary Medical Association, 1974
SUMMARY The historical and laboratory findings in 5 published reports and 3 additional cases of polycythemia vera in the dog were reviewed. The consistent abnormal findings included increased packed cell volume (pcv), hemoglobin concentration, red blood cell (rbc) count, rbc mass, and total blood volume.
openaire +2 more sources
SUMMARY The historical and laboratory findings in 5 published reports and 3 additional cases of polycythemia vera in the dog were reviewed. The consistent abnormal findings included increased packed cell volume (pcv), hemoglobin concentration, red blood cell (rbc) count, rbc mass, and total blood volume.
openaire +2 more sources
Apoptosis and polycythemia vera
Current Opinion in Hematology, 1999Polycythemia vera is an acquired clonal myeloproliferative disorder characterized by increased numbers of erythroid cells, often with a concomitant rise in neutrophils and/or megakaryocytes. Normally, erythropoietin is essential for the survival and proliferation of erythroid progenitors; however in polycythemia vera the erythroid progenitor cells can ...
openaire +2 more sources
POLYCYTHEMIA VERA IN CHILDHOOD
Archives of Pediatrics & Adolescent Medicine, 1972To the Editor.—The recent communication by Natelson et al1at the first glance appears to add another report to the compendium of chromosomal abnormalities, specific or nonspecific, as the case may be. The nonspecific chromosomal abnormalities probably are not significant since they may not have any relation to the clinical nature or etiology of the ...
openaire +2 more sources
Treatment of Polycythemia Vera
Seminars in Thrombosis and Hemostasis, 2006The selection of treatment for patients with polycythemia vera (PV) still is the subject of much discussion among hematologists. It is emphasized that important physiologic and pathogenic components of the illness relate not only to the erythroid cell, but also to the megakaryocyte.
openaire +2 more sources